Vischer with Medartis on KeriMedical acquisition
Vischer advised Medartis, an SIX-listed orthopedic company with headquarters in Basel specialising in head and extremity surgery, on its acquisition of the remaining 53% of Geneva-based KeriMedical. Pursuant to the deal, Medartis becomes the sole owner of the company. The remaining shares value at CHF 99 million, plus potential additional earn-out payments.
The context
The selling part KeriMedical is a provider of implants for hand and wrist surgery. The partnership between the company and Medartis goes back to 2020, when the latter started serving as the exclusive distributor for KeriMedical products in several European countries and Australia, gradually increasing its stake.
The Vischer team
The Vischer team working on the matter included partner Christian Wyss (corporate/M&A, pictured), managing associates Luzius Zumstein (corporate/M&A) and Pauline Pfirter (corporate/M&A), as well as associate Rahel Widmer (corporate/M&A).
